Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Brain atrophy and cognitive deficits in Cushing's disease.

Patil CG, Lad SP, Katznelson L, Laws ER Jr.

Neurosurg Focus. 2007;23(3):E11. Review.

PMID:
17961025
2.

Neuropsychiatric disorders and cognitive dysfunction in patients with Cushing's disease.

Chen YF, Li YF, Chen X, Sun QF.

Chin Med J (Engl). 2013 Aug;126(16):3156-60. Review.

PMID:
23981629
3.

Reversible "brain atrophy" in patients with Cushing's disease.

Gnjidić Z, Sajko T, Kudelić N, Malenica M, Vizner B, Vrkljan M, Hat J, Rumboldt Z.

Coll Antropol. 2008 Dec;32(4):1165-70.

PMID:
19149224
4.

Volumetric MRI analysis of hippocampal subregions in Cushing's disease: a model for glucocorticoid neural modulation.

Toffanin T, Nifosì F, Follador H, Passamani A, Zonta F, Ferri G, Scanarini M, Amistà P, Pigato G, Scaroni C, Mantero F, Carollo C, Perini GI.

Eur Psychiatry. 2011 Jan;26(1):64-7. doi: 10.1016/j.eurpsy.2010.09.003. Epub 2010 Nov 9.

PMID:
21067899
5.

Subtle cognitive impairments in patients with long-term cure of Cushing's disease.

Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BJ, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA.

J Clin Endocrinol Metab. 2010 Jun;95(6):2699-714. doi: 10.1210/jc.2009-2032. Epub 2010 Apr 6.

PMID:
20371667
6.

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

Sapolsky RM.

Arch Gen Psychiatry. 2000 Oct;57(10):925-35. Review.

PMID:
11015810
7.

Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study.

Andela CD, van der Werff SJ, Pannekoek JN, van den Berg SM, Meijer OC, van Buchem MA, Rombouts SA, van der Mast RC, Romijn JA, Tiemensma J, Biermasz NR, van der Wee NJ, Pereira AM.

Eur J Endocrinol. 2013 Oct 21;169(6):811-9. doi: 10.1530/EJE-13-0471. Print 2013 Dec.

8.

[Effects of glucocorticoids administration on memory. Cognitive impairment in Cushing's disease].

Martin-Du Pan RC, Berney P.

Rev Med Suisse. 2012 Nov 14;8(362):2165-6, 2168-9. French.

PMID:
23240317
9.

Possible mechanisms for atrophy of the human hippocampus.

McEwen BS.

Mol Psychiatry. 1997 May;2(3):255-62. Review.

PMID:
9152991
10.

Glucocorticoid resistance and hypersensitivity.

Malchoff CD, Malchoff DM.

Endocrinol Metab Clin North Am. 2005 Jun;34(2):315-26, viii. Review.

PMID:
15850844
11.

Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.

Teshima T, Hara Y, Takekoshi S, Teramoto A, Osamura RY, Tagawa M.

Domest Anim Endocrinol. 2009 Jan;36(1):3-12. doi: 10.1016/j.domaniend.2008.08.002. Epub 2008 Sep 18.

PMID:
18818046
12.

Brain atrophy and cognitive impairment in multiple sclerosis: a review.

Lanz M, Hahn HK, Hildebrandt H.

J Neurol. 2007 May;254 Suppl 2:II43-8. Review. Erratum in: J Neurol. 2008 Feb;255(2):309-10.

PMID:
17503128
13.

Cognitive function and cerebral assessment in patients who have Cushing's syndrome.

Bourdeau I, Bard C, Forget H, Boulanger Y, Cohen H, Lacroix A.

Endocrinol Metab Clin North Am. 2005 Jun;34(2):357-69, ix. Review.

PMID:
15850847
14.

Antiglucocorticoid drugs in the treatment of depression.

Reus VI, Wolkowitz OM.

Expert Opin Investig Drugs. 2001 Oct;10(10):1789-96. Review.

PMID:
11772285
15.

[Cushing's syndrome: special issues].

Goñi Iriarte MJ.

Endocrinol Nutr. 2009 May;56(5):251-61. doi: 10.1016/S1575-0922(09)71408-1. Epub 2009 Jul 1. Review. Spanish.

PMID:
19627746
16.

Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging.

Michaud K, Forget H, Cohen H.

Brain Cogn. 2009 Oct;71(1):1-8. doi: 10.1016/j.bandc.2009.02.013. Epub 2009 May 9.

PMID:
19428166
17.

Fatal course of cyclic Cushing's disease - lessons from a case.

Baszko-Blaszyk D, Ziemnicka K, Waśko R, Pietz L, Waligórska-Stachura J, Gut P, Biczysko M, Sowiński J.

Neuro Endocrinol Lett. 2011;32(3):238-41.

PMID:
21712786
18.

Work-up and management of paediatric Cushing's syndrome.

Savage MO, Chan LF, Grossman AB, Storr HL.

Curr Opin Endocrinol Diabetes Obes. 2008 Aug;15(4):346-51. doi: 10.1097/MED.0b013e328305082f. Review.

PMID:
18594275
19.

[Prevalence, etiology and clinical findings of Cushing's syndrome].

Lahera Vargas M, da Costa CV.

Endocrinol Nutr. 2009 Jan;56(1):32-9. doi: 10.1016/S1575-0922(09)70191-3. Epub 2009 Mar 1. Review. Spanish.

PMID:
19627706
20.

An approach to the management of patients with residual Cushing's disease.

Blevins LS Jr, Sanai N, Kunwar S, Devin JK.

J Neurooncol. 2009 Sep;94(3):313-9. doi: 10.1007/s11060-009-9888-2. Epub 2009 Apr 19. Review.

Supplemental Content

Support Center